Skip to Content

Posts tagged with "Life in the Drug Labs"

  • Drug Industry History

    How Many Chemists Have You Seen on a Team?

    I’m traveling today to give a talk (at this regional meeting of the AAPS), so I don’t have my usual train commute wherein to do the morning blog post. So I wanted to set off a bit of discussion instead. I had an email from someone whose boss was at Merck during the Ed Skolnik… Read More
  • Chemical News

    Phosphorus And Me. Or Maybe You First.

    A commenter mentioned fosfomycin in this morning’s post, which prompts me to put its structure up for those who don’t know the compound. Now that’s a strange little beast. It’s a natural product, as you might well think – who’s going to make that on purpose? And it’s also a pretty decent antibacterial, as a… Read More
  • Life in the Drug Labs

    Five Tons of TiCl4

    I would definitely not want to be downwind of the release of five tons of titanium tetrachloride. This happened near Montreal over the weekend, and things seem to have turned out a lot better than one might have imagined (only two people hospitalized). For those who haven’t worked with it, “tickle-four” fumes wildly on contact… Read More
  • Chemical News

    What Compound Will You Never Forget?

    While catching up on the literature today, I find that even now, thirty years later, I can’t look at a paper that uses 1,6-anhydroglucose (levoglucosan to its friends) without a quick, simultaneous flicker of interest and shiver of dread. This is why. So fellow chemist, what’s yours? What compound will you never forget, because it… Read More
  • Life in the Drug Labs

    OK, You San Diego People

    I’ve already been hearing from people out on the West Coast about how it’s seventy-odd Fahrenheit out there. My first thought was “It’s five AM out in San Diego; why aren’t you asleep rather than looking at the thermometer?” But as for the Cambridge/Boston biopharma world, yeah, we’re mostly at home today.… Read More
  • Life in the Drug Labs

    Tolerant Chemistry: Be Glad of It

    Like a lot of other scientists in the Northeast today, I’m getting things in the lab ready for me not being there tomorrow. (I just ran into a colleague who didn’t know that we’re set to get two to three feet of snow, distributed by 50 mile-per-hour winds, over the next 36 hours, and he… Read More
  • Chemical News

    Get Your Spirocyclic Compounds Here

    If you do early-stage medicinal chemistry, you’ll probably be interested in this overview of spirocyclic scaffolds. It has examples from the recent literature, and an update on synthetic methods to get into this chemical space. I’ve made several compounds like this over the years, without much success in the assays so far. But as the… Read More
  • Life in the Drug Labs

    Not So Scalable

    Unworkable compounds are one thing. Unworkable processes and reactions are just as big a problem, though. You don’t see as many paper proposing those as you do the ones advancing squirrely chemical matter, but they’re out there. Here’s an example from Quintus, who takes a look at this paper‘s route to some prostaglandin inte… Read More
  • Life in the Drug Labs

    Enjoying The Open Office

    I’ve conveyed my dislike of wide-open office plans several times, and my suspicions of the motives of those who promote them. Here’s an article at the Washington Post that confirms my own biases (and is therefore stunningly accurate): As the new space intended, I’ve formed interesting, unexpected bonds with my cohorts. But my personal… Read More
  • Business and Markets

    That Same Sort of Job

    I was reading this interesting commentary on the bizarre meltdown of The New Republic, when something struck me. Megan McArdle is talking here about how hard it can be to manage journalists: Both journalists and non-journalists usually fail to understand just how weirdly different media companies are from other sorts of firms, which means they… Read More